當(dāng)前位置:杭州昊鑫生物科技股份有限公司>>MCE>> HY-136057iFSP1
HY-136057
MCE
代理商
杭州市
10mg 480元 10000支可售
聯(lián)系方式:鄧女士查看聯(lián)系方式
更新時間:2024-06-24 17:18:06瀏覽次數(shù):183次
聯(lián)系我時,請告知來自 制藥網(wǎng)CAS號 | 150651-39-1 | 產(chǎn)地 | 國產(chǎn) |
---|---|---|---|
規(guī)格 | 10mg | 級別 | 化工級 |
證書 | ISO系列證書 |
iFSP1 是 FSP1 (AIFM2) 的選擇性有效抑制劑,EC50 值為 103 nM。iFSP1 可選擇性地誘導(dǎo)過表達(dá) FSP1 的 GPX4 敲除細(xì)胞發(fā)生鐵死亡 (ferroptosis)。iFSP1 可增強(qiáng)多種人ai細(xì)胞系對鐵死亡誘導(dǎo)劑的敏感度,如: (1S,3R)-RSL3 (HY-100218A)。
生物活性
iFSP1 is a potent, selective and glutathione-independent inhibitor of ferroptosis suppressor protein 1 (FSP1) (AIFM2) with an EC50 of 103 nM. iFSP1 selectively induces ferroptosis in GPX4-knockout cells which overexpressed FSP1. iFSP1 is able to sensitize a variety of human cancer cell lines to the ferroptosis inducer, such as (1S,3R)-RSL3 (HY-100218A)[1].
IC50 & Target
EC50: 103 nM (FSP1)[1]
體外研究(In Vitro)
iFSP1 (0.001-1 μM; 24 hours) inhibits the Gpx4-knockout cell growth as a dose-dependent manner, but does not inhibit the wild type cell growth. Treatment with the ferroptosis inhibitor Lip-1 protects GPX4- knockout cells from iFSP1-induced ferroptosis[1].
iFSP1 (0.001-1 μM; 24 hours) is less efficient than genetic deletion of FSP1, whereas iFSP1 treatment in the FSP1-knockout background had no additive effect to RSL3-induced ferroptosis[1].
iFSP1 (3 μM; 24 hours) treatment results in an obvious toxicity of RSL3 in a panel of genetically engineered (FSP1-knockout) human cancer cell lines[1].
AIFM2: the flavoprotein apoptosis-inducing factor mitochondria-associated 2 is a previously unrecognized anti-ferroptotic gene. AIFM2, which is renamed ferroptosis suppressor protein 1 (FSP1)[1]
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay[1]
Cell Line: | Wild-type and Gpx4-knockout Pfa1 or HT 1080 cells overexpressing FSP1–HA |
Concentration: | 0.001-1 μM |
Incubation Time: | 24 hours |
Result: | Was toxic to cells that depend solely (no GPX4 expression detectable) on FSP1 function. |
分子量:323.35
性狀:Solid
Formula:C20H13N5
CAS 號:150651-39-1
運(yùn)輸條件
Room temperature in continental US; may vary elsewhere.
儲存方式
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
溶解性數(shù)據(jù)
DMSO : 20 mg/mL (61.85 mM; Need ultrasonic)
濃度溶劑體積質(zhì)量 | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.0926 mL | 15.4631 mL | 30.9262 mL |
5 mM | 0.6185 mL | 3.0926 mL | 6.1852 mL |
10 mM | 0.3093 mL | 1.5463 mL | 3.0926 mL |
請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;一旦配成溶液,請分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 儲存時,請?jiān)?6 個月內(nèi)使用,-20°C 儲存時,請?jiān)?1 個月內(nèi)使用。
以下溶解方案都請先按照 In Vitro 方式配制澄清的儲備液,再依次添加助溶劑:
——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲備液可以根據(jù)儲存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過加熱和/或超聲的方式助溶
請依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% saline
Solubility: 2 mg/mL (6.19 mM); Suspended solution; Need ultrasonic
參考文獻(xiàn)
[1]. Doll S, et al. FSP1 is a glutathione-independent ferroptosis suppressor.Nature. 2019 Nov;575(7784):693-698. [Content Brief]
注:產(chǎn)品僅用于科研
請輸入賬號
請輸入密碼
請輸驗(yàn)證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),制藥網(wǎng)對此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購買風(fēng)險(xiǎn),建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。